Health and economic outcomes of 20-valent pneumococcal conjugate vaccine compared to 15-valent pneumococcal conjugate vaccine strategies for adults in Greece

OBJECTIVE: Higher valency pneumococcal conjugate vaccines (PCVs) are expected to improve protection against pneumococcal disease through coverage of additional serotypes. The aim of the present study was to evaluate the cost-effectiveness of 20-valent pneumococcal conjugate vaccine (PCV20) compared...

Descripción completa

Detalles Bibliográficos
Autores principales: Gourzoulidis, George, Barmpouni, Myrto, Kossyvaki, Vasiliki, Vietri, Jeffrey, Tzanetakos, Charalampos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570410/
https://www.ncbi.nlm.nih.gov/pubmed/37841729
http://dx.doi.org/10.3389/fpubh.2023.1229524

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570410/
https://www.ncbi.nlm.nih.gov/pubmed/37841729
http://dx.doi.org/10.3389/fpubh.2023.1229524

Ejemplares similares